Customised chemotherapy for lung cancer
Symposium Chairs: J-P. Sculier (Brussels, Belgium), E. Quoix (Strasbourg, France)
Aims: The audience should recognise that chemotherapy regimens for lung cancer are no longer only on the simple differentiation between small cell and nonsmall cell lung cancer. Present and future treatment strategies should be based on the molecular biological properties of the tumour.